Dashenlin Pharmaceutical to host 2025 half-year performance briefing

Dashenlin Pharmaceutical Group Co., Ltd. will hold its 2025 semi-annual performance briefing on September 26, 2025, from 4:00 PM to 5:00 PM. The briefing follows the release of the company's 2025 half-year report on August 29, 2025, and aims to provide investors with a comprehensive understanding of its operational and financial performance.

The virtual event will take place on the Shanghai Stock Exchange Roadshow Center (https://roadshow.sseinfo.com/), utilizing an online interactive format. Investors can submit questions in advance from September 19, 2025, to September 25, 2025, at 4:00 PM, via the "Question Collection" section on the roadshow website or by emailing DSL1999@dslyy.com. The company will address these questions during the briefing.

Key participants from Dashenlin Pharmaceutical will include chairman and general manager Ke Guoqiang, board secretary and CFO Peng Guangzhi, and independent director Lu Liping. Inquiries can be directed to the company's board secretariat at 020-81689688 or via email at DLS1999@dslyy.com.